Overexpression of CIITA in T cells aggravates Th2-mediated colitis in mice

Journal of Korean Medical Science

Volumn 21, Issue 5, 2006, Pages 877-882

  Tae, Woon Kim ^a   Hyo, Jin Park ^b   Eun, Young Choi ^b   Kyeong, Cheon Jung ^b  

^a Hallym University   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

CIITA protein; Inflammatory bowel diseases; Interleukin 4; MHC class II transactivator protein; Th2 cells

Indexed keywords

EID: 33750257307     PISSN: 10118934     EISSN: 15986357     Source Type: Journal    
DOI: 10.3346/jkms.2006.21.5.877     Document Type: Article

References (20)

1. Chang CH, Fontes JD, Peterlin M, Flavell RA. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J Exp Med 1994; 180: 1367-74.
2. Steimle V, Siegrist CA, Mottet A, Lisowska-Grospierre B, Mach B. Regulation of MHC class II expression by interferon-γ mediated by the transactivator gene CIITA. Science 1994; 265: 106-9.
3. Chang CH, Flavell RA. Class II transactivator regulates the expression of multiple genes involved in antigen presentation. J Exp Med 1995; 181: 765-7.
4. Dong Y, Rohn WM, Benveniste EN. IFN-γ regulation of the type IV class II transactivator promoter in astrocytes. J Immunol 1999; 162: 4731-9.
5. Ting JP, Trowsdale J. Genetic control of MHC class II expression. Cell 2002; 109 (Suppl): 21-33.
6. Xu Y, Wang L, Buttice G, Sengupta PK, Smith BD. Major histocompatibility class II transactivator (CIITA) mediates repression of collagen (COL1A2) transcription by interferon γ (IFN-γ). J Biol Chem 2004; 279: 41319-32.
7. Nozell S, Ma Z, Wilson C, Shah R, Benveniste EN. Class II major histocompatibility complex transactivator (CIITA) inhibits matrix metalloproteinase-9 gene expression. J Biol Chem 2004; 279: 38577-89.
8. Sisk TJ, Gourley T, Roys S, Chang CH. MHC class II transactivator inhibits IL-4 gene transcription by competing with NF-AT to bind the coactivator CREB binding protein (CBP)/p300. J Immunol 2000; 165: 2511-7.
9. Gourley TS, Chang CH. Cutting edge: the class II transactivator prevents activation-induced cell death by inhibiting fas ligand gene expression. J Immunol 2001; 166: 2917-21.
10. Montani V, Shong M, Taniguchi SI, Suzuki K, Giuliani C, Napolitano G, Saito J, Saji M, Fiorentino B, Reimold AM, Singer DS, Kohn LD. Regulation of major histocompatibility class II gene expression in FRTL-5 thyrocytes: opposite effects of interferon and methimazole. Endocrinology 1998; 139: 290-302.
11. Kim WB, Kim TY, Park YJ, Koh JJ, Park DJ, Cho BY. Effect of class 2 transactivator on expression of thyroid transcription factor-1 in FRTL-5 cells. J Korean Soc Endocrinol 2002; 17: 48-56.
12. Gourley T, Roys S, Lukacs NW, Kunkel SL, Flavell RA, Chang CH. A novel role for the major histocompatibility complex class II transactivator CIITA in the repression of IL-4 production. Immunity 1999; 10: 377-86.
13. Park WS, Bae Y, Chung DH, Choi YL, Kim BK, Sung YC, Choi EY, Park SH, Jung KC. T cell expression of CIITA represses Th1 immunity. Int Immunol 2004; 16: 1355-64.
14. + T lymphocytes. J Immunol 2003; 170: 1150-7.
15. Boirivant M, Fuss IJ, Chu A, Strober W. Oxazolone colitis: A murine model of T helper cell type 2 colitis treatable with antibodies to interleukin 4. J Exp Med 1998; 188: 1929-39.
16. Heller F, Fuss IJ, Nieuwenhuis EE, Blumberg RS, Strober W. Oxazolone colitis, a Th2 colitis model resembling ulcerative colitis, is mediated by IL-13-producing NK-T cells. Immunity 2002; 17: 629-38.
17. Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 1990; 98: 694-702.
18. Gourley TS, Patel DR, Nickerson K, Hong SC, Chang CH. Aberrant expression of fas ligand in mice deficient for the MHC class II transactivator. J Immunol 2002; 168: 4414-9.
19. Chensue SW, Warmington K, Ruth J, Lincoln P, Kuo MC, Kunkel SL. Cytokine responses during mycobacterial and schistosomal antigen-induced pulmonary granuloma formation. Production of Th1 and Th2 cytokines and relative contribution of tumor necrosis factor. Am J Pathol 1994; 145: 1105-13.
20. Hibi T, Ogata H, Sakuraba A. Animal models of inflammatory bowel disease. J Gastroenterol 2002; 37: 409-17.